explore -WSS

explore

author：Wikipedia 2025-09-29 18:18:22 - browse：737

gantenerumab Alzheimer's disease Roche — Sebastien Bozon/AFP via Getty Images

LONDON — Roche on Thursday said its recently acquired experimental obesity medication helped people lose a significant amount of weight in an early trial, sending its shares up in early trading.

The drug, a once-weekly injection known as CT-388, resulted in an average placebo-adjusted weight loss of 18.8% after 24 weeks, the company said. The study was a Phase 1 trial, though it was placebo-controlled.

The reaction to such an early result — Roche shares were up roughly 4% early Thursday — is a signal both of the stakes of the obesity medication race and the keen interest investors have in the field.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： 5 dead in mass shooting on Caribbean island of St. Vincent: Police

Wikipedia

WSS

FDA does about

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

5 dead in mass shooting on Caribbean island of St. Vincent: Police

Why getting cancer drugs just got harder for rural patients

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

Why getting cancer drugs just got harder for rural patients

explore

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

knowledge

Moonlake's readout produced a cash windfall. Risks remain

ALS groups 'won't be played again' by the FDA, drug sponsors

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Sanders wants to replace patents with prizes for drug inventions

Medicare proposal to cover medical devices draws a mixed reaction

International team creates first chimeric human

Moonlake's readout produced a cash windfall. Risks remain

Congress gives doctors Medicare pay bump

Peter Hotez and the public health issue of online harassment

Judge denies Trump's request for new trial in E. Jean Carroll case

knowledge

Are infertility treatments 'essential' during the Covid

There’s a way to spot data fakery. All journals should be using it

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

How to address the problem of discarded donor organs

Judge denies Trump's request for new trial in E. Jean Carroll case

'CMA Fest' 2023: How to watch, who is performing and more

Wikipedia

explore

knowledge

leisure time